Future research directions in acute lung injury

Summary of a National Heart, Lung, and Blood Institute Working Group

Michael A. Matthay, Guy A. Zimmerman, Charles Esmon, Jahar Bhattacharya, Barry Coller, Claire M. Doerschuk, Joanna Floros, Michael A. Gimbrone, Eric Hoffman, Rolf D. Hubmayr, Mark Leppert, Sadis Matalon, Robert Munford, Polly Parsons, Arthur S. Slutsky, Kevin J. Tracey, Peter Ward, Dorothy B. Gail, Andrea L. Harabin

Research output: Contribution to journalArticle

422 Citations (Scopus)

Abstract

Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmonary edema and inflammation. The development of ALI/ARDS is associated with several clinical disorders including direct pulmonary injury from pneumonia and aspiration as well as indirect pulmonary injury from trauma, sepsis, and other disorders such as acute pancreatitis and drug overdose. Although mortality from ALI/ARDS has decreased in the last decade, it remains high. Despite two major advances in treatment, low VT ventilation for ALI/ARDS and activated protein C for severe sepsis (the leading cause of ALI/ARDS), additional research is needed to develop specific treatments and improve understanding of the pathogenesis of these syndromes. The NHLBI convened a working group to develop specific recommendations for future ALI/ARDS research. Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI. Cellular and molecular methods combined with animal and clinical studies should lead to further progress in the detection and treatment of this complex disease.

Original languageEnglish (US)
Pages (from-to)1027-1035
Number of pages9
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume167
Issue number7
DOIs
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Acute Lung Injury
Adult Respiratory Distress Syndrome
Lung Injury
Sepsis
Drug Overdose
Aspiration Pneumonia
Pulmonary Edema
Protein C
Direction compound
Research
Respiratory Insufficiency
Pancreatitis
Ventilation
Pneumonia
Therapeutics
Mortality
Wounds and Injuries

Keywords

  • Acute respiratory distress syndrome
  • Critical care
  • Genomics
  • Pulmonary edema
  • Pulmonary inflammation

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Future research directions in acute lung injury : Summary of a National Heart, Lung, and Blood Institute Working Group. / Matthay, Michael A.; Zimmerman, Guy A.; Esmon, Charles; Bhattacharya, Jahar; Coller, Barry; Doerschuk, Claire M.; Floros, Joanna; Gimbrone, Michael A.; Hoffman, Eric; Hubmayr, Rolf D.; Leppert, Mark; Matalon, Sadis; Munford, Robert; Parsons, Polly; Slutsky, Arthur S.; Tracey, Kevin J.; Ward, Peter; Gail, Dorothy B.; Harabin, Andrea L.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 167, No. 7, 01.04.2003, p. 1027-1035.

Research output: Contribution to journalArticle

Matthay, MA, Zimmerman, GA, Esmon, C, Bhattacharya, J, Coller, B, Doerschuk, CM, Floros, J, Gimbrone, MA, Hoffman, E, Hubmayr, RD, Leppert, M, Matalon, S, Munford, R, Parsons, P, Slutsky, AS, Tracey, KJ, Ward, P, Gail, DB & Harabin, AL 2003, 'Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute Working Group', American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 7, pp. 1027-1035. https://doi.org/10.1164/rccm.200208-966WS
Matthay, Michael A. ; Zimmerman, Guy A. ; Esmon, Charles ; Bhattacharya, Jahar ; Coller, Barry ; Doerschuk, Claire M. ; Floros, Joanna ; Gimbrone, Michael A. ; Hoffman, Eric ; Hubmayr, Rolf D. ; Leppert, Mark ; Matalon, Sadis ; Munford, Robert ; Parsons, Polly ; Slutsky, Arthur S. ; Tracey, Kevin J. ; Ward, Peter ; Gail, Dorothy B. ; Harabin, Andrea L. / Future research directions in acute lung injury : Summary of a National Heart, Lung, and Blood Institute Working Group. In: American Journal of Respiratory and Critical Care Medicine. 2003 ; Vol. 167, No. 7. pp. 1027-1035.
@article{26a35325c20d453fbbe48e8db38e1a6c,
title = "Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute Working Group",
abstract = "Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmonary edema and inflammation. The development of ALI/ARDS is associated with several clinical disorders including direct pulmonary injury from pneumonia and aspiration as well as indirect pulmonary injury from trauma, sepsis, and other disorders such as acute pancreatitis and drug overdose. Although mortality from ALI/ARDS has decreased in the last decade, it remains high. Despite two major advances in treatment, low VT ventilation for ALI/ARDS and activated protein C for severe sepsis (the leading cause of ALI/ARDS), additional research is needed to develop specific treatments and improve understanding of the pathogenesis of these syndromes. The NHLBI convened a working group to develop specific recommendations for future ALI/ARDS research. Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI. Cellular and molecular methods combined with animal and clinical studies should lead to further progress in the detection and treatment of this complex disease.",
keywords = "Acute respiratory distress syndrome, Critical care, Genomics, Pulmonary edema, Pulmonary inflammation",
author = "Matthay, {Michael A.} and Zimmerman, {Guy A.} and Charles Esmon and Jahar Bhattacharya and Barry Coller and Doerschuk, {Claire M.} and Joanna Floros and Gimbrone, {Michael A.} and Eric Hoffman and Hubmayr, {Rolf D.} and Mark Leppert and Sadis Matalon and Robert Munford and Polly Parsons and Slutsky, {Arthur S.} and Tracey, {Kevin J.} and Peter Ward and Gail, {Dorothy B.} and Harabin, {Andrea L.}",
year = "2003",
month = "4",
day = "1",
doi = "10.1164/rccm.200208-966WS",
language = "English (US)",
volume = "167",
pages = "1027--1035",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "7",

}

TY - JOUR

T1 - Future research directions in acute lung injury

T2 - Summary of a National Heart, Lung, and Blood Institute Working Group

AU - Matthay, Michael A.

AU - Zimmerman, Guy A.

AU - Esmon, Charles

AU - Bhattacharya, Jahar

AU - Coller, Barry

AU - Doerschuk, Claire M.

AU - Floros, Joanna

AU - Gimbrone, Michael A.

AU - Hoffman, Eric

AU - Hubmayr, Rolf D.

AU - Leppert, Mark

AU - Matalon, Sadis

AU - Munford, Robert

AU - Parsons, Polly

AU - Slutsky, Arthur S.

AU - Tracey, Kevin J.

AU - Ward, Peter

AU - Gail, Dorothy B.

AU - Harabin, Andrea L.

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmonary edema and inflammation. The development of ALI/ARDS is associated with several clinical disorders including direct pulmonary injury from pneumonia and aspiration as well as indirect pulmonary injury from trauma, sepsis, and other disorders such as acute pancreatitis and drug overdose. Although mortality from ALI/ARDS has decreased in the last decade, it remains high. Despite two major advances in treatment, low VT ventilation for ALI/ARDS and activated protein C for severe sepsis (the leading cause of ALI/ARDS), additional research is needed to develop specific treatments and improve understanding of the pathogenesis of these syndromes. The NHLBI convened a working group to develop specific recommendations for future ALI/ARDS research. Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI. Cellular and molecular methods combined with animal and clinical studies should lead to further progress in the detection and treatment of this complex disease.

AB - Acute lung injury (ALI) and its more severe form, the acute respiratory distress syndrome (ARDS), are syndromes of acute respiratory failure that result from acute pulmonary edema and inflammation. The development of ALI/ARDS is associated with several clinical disorders including direct pulmonary injury from pneumonia and aspiration as well as indirect pulmonary injury from trauma, sepsis, and other disorders such as acute pancreatitis and drug overdose. Although mortality from ALI/ARDS has decreased in the last decade, it remains high. Despite two major advances in treatment, low VT ventilation for ALI/ARDS and activated protein C for severe sepsis (the leading cause of ALI/ARDS), additional research is needed to develop specific treatments and improve understanding of the pathogenesis of these syndromes. The NHLBI convened a working group to develop specific recommendations for future ALI/ARDS research. Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI. Cellular and molecular methods combined with animal and clinical studies should lead to further progress in the detection and treatment of this complex disease.

KW - Acute respiratory distress syndrome

KW - Critical care

KW - Genomics

KW - Pulmonary edema

KW - Pulmonary inflammation

UR - http://www.scopus.com/inward/record.url?scp=0345701397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345701397&partnerID=8YFLogxK

U2 - 10.1164/rccm.200208-966WS

DO - 10.1164/rccm.200208-966WS

M3 - Article

VL - 167

SP - 1027

EP - 1035

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 7

ER -